Page last updated: 2024-09-03
gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Pneumococcal Infections
gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide has been researched along with Pneumococcal Infections in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Banniettis, N; Benfield, T; Bickham, K; Churchill, C; Dagan, R; Kaminski, J; Lupinacci, R; McFetridge, R; Mercer, S; Musey, L; Park, J; Rämet, M; Richmond, P; Seppä, I; Valentini, P; Wittke, F | 1 |
Trials
1 trial(s) available for gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide and Pneumococcal Infections
| Article | Year |
|---|---|
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Topics: Antibodies, Bacterial; Haemophilus influenzae type b; Hepatitis B Vaccines; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Infant; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Tetanus; Tetanus Toxoid; Vaccines, Conjugate | 2023 |